NCT06715475 is a NA clinical trial of Food containing plasmalogen in Healthy Japanese, sponsored by Orthomedico Inc..

Who is sponsoring NCT06715475?

NCT06715475 is sponsored by Orthomedico Inc..

What drugs are being tested in NCT06715475?

Interventions in NCT06715475: Food containing plasmalogen, Food not containing plasmalogen.

What condition does NCT06715475 study?

NCT06715475 studies Healthy Japanese.

Is NCT06715475 still recruiting?

NCT06715475 is currently active, enrolled. Last updated 1 April 2025.

Last reviewed 2025-04-01 · How we verify

NCT06715475

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Verification Study to Evaluate the Safety of Long-term Consumption of the Test Food

Active, enrolled NA Last updated 1 April 2025

What this trial tests

NA trial testing Food containing plasmalogen in Healthy Japanese in 24 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

2 December 2024

Primary endpoint
23 April 2025

23 April 2025

Quick facts

Lead sponsor	Orthomedico Inc.
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	24
Start date	2 December 2024
Primary completion	23 April 2025
Estimated completion	23 April 2025
Sites	2 locations across Japan

Drugs / interventions tested

Food containing plasmalogen
Food not containing plasmalogen

Conditions studied

Healthy Japanese — all drugs for Healthy Japanese →

Sponsor

Orthomedico Inc.

Who can join

18 and older, any sex, with Healthy Japanese. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical study aims to verify the safety of consumption of plasmalogen-containing food for 12 weeks in healthy Japanese. The study will also exploratory assess blood plasmalogen levels and the effects of plasmalogen-containing food on sleep.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Plasmalogens as biomarkers and therapeutic targets.
Curran CS, Remaley AT, Torabi-Parizi P. · · 2025 · PMID 41130295 · DOI 10.1016/j.jlr.2025.100925

Verify or expand the search:

Other trials of Food containing plasmalogen

Trials testing the same drug.

NCT06907537 — A Study to Verify the Sleep-improving Effects of the Test Food Consumption · NA · completed

Other recruiting trials for Healthy Japanese

Currently open trials in the same condition.

NCT07393126 — Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults · NA · recruiting

Other Orthomedico Inc. trials

Trials by the same sponsor.

NCT06907537 — A Study to Verify the Sleep-improving Effects of the Test Food Consumption · NA · completed
NCT05962008 — Effects of Consumption of Phosphatidylserine on the Cognitive Function · NA · completed
NCT05683327 — The Effect of Oral Hyaluronic Acid (UltraHA®) on the Knee Function · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06715475 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Orthomedico Inc.
Last refreshed: 1 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06715475.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing